Established rheumatoid arthritis: clinical assessments

Area of Science:

• Rheumatology
• Clinical Assessment
• Disease Monitoring

Background:

• Clinical assessment in established rheumatoid arthritis (RA) serves multiple purposes, including prognosis evaluation, disease course tracking, and intervention assessment.
• Prognostic factors are valuable for risk-benefit analysis of early pharmacotherapy but have limited utility in established RA patient management.
• Individual RA disease activity, disability, and joint damage exhibit variable courses, necessitating regular monitoring.

Purpose of the Study:

• To outline the diverse applications of clinical assessment in established rheumatoid arthritis (RA).
• To highlight the importance of regular monitoring of disease activity, disability, and joint damage.
• To discuss the utility of process and outcome measures in evaluating RA interventions and clinical practice.

Main Methods:

• Review of established methods for clinical assessment in rheumatoid arthritis (RA).
• Discussion of process measures (e.g., erythrocyte sedimentation rate, joint counts) and outcome measures (e.g., radiological progression).
• Examination of 'core sets' of measures for evaluating interventions and clinical practice.

Main Results:

• Clinical assessment is vital for evaluating prognosis, disease course, and interventions in RA at individual and group levels.
• Regular evaluation using both process and outcome measures is essential for managing established RA due to variable disease courses.
• Standardized 'core sets' of measures are effective for evaluating RA interventions and can inform clinical practice.

Conclusions:

• Comprehensive and regular clinical assessment, employing both process and outcome measures, is fundamental for effective rheumatoid arthritis (RA) management.
• The choice of assessment instruments should align with the specific purpose, whether for prognosis, disease course monitoring, or intervention evaluation.
• Standardized assessment tools can enhance the evaluation of RA treatments and contribute to improved clinical practice.